drugset
drugset / Trial / NCT02664909

Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty

NCT02664909 ↗

Phase 4 Completed 36 enrolled UConn Health Orthopedic Research and Education Foundation · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a double-blinded placebo-controlled clinical trial evaluating the efficacy of 1 gram of topically applied tranexamic acid vs. saline placebo for the reduction of transfusion following hip hemiarthroplasty surgery.

Timeline

Start
2016-01-01
Primary completion
2019-06-30
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Topical

Indications

No indication recorded.